https://doi.org/10.1016/j.jtho.2021.04.011
J
Jian Fang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
245
Papers
6.4K
Citations
35
h-index
91
i10-index
Jian Fang is an academic researcher from Peking University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Colorectal Cancer Treatments and Studies. The author has an h-index of 35, co-authored 209 publications.
ORCID: 0000-0003-3697-4563Papers by this author
worksSintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
2021 · Journal of Thoracic Oncology · 299 citations
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial
2022 · Molecular Cancer · 53 citations
https://doi.org/10.1186/s12943-021-01479-4
Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial
2023 · EClinicalMedicine · 48 citations
https://doi.org/10.1016/j.eclinm.2023.101952
EPA and DHA differentially coordinate the crosstalk between host and gut microbiota and block DSS-induced colitis in mice by a reinforced colonic mucus barrier
2022 · Food & Function · 39 citations
https://doi.org/10.1039/d1fo03815j
Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial
2022 · Signal Transduction and Targeted Therapy · 34 citations
https://doi.org/10.1038/s41392-021-00841-8
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations
2022 · JTO Clinical and Research Reports · 26 citations
https://doi.org/10.1016/j.jtocrr.2022.100407
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat